183 related articles for article (PubMed ID: 20713982)
1. Expression of serum amyloid a in human ovarian epithelial tumors: implication for a role in ovarian tumorigenesis.
Urieli-Shoval S; Finci-Yeheskel Z; Dishon S; Galinsky D; Linke RP; Ariel I; Levin M; Ben-Shachar I; Prus D
J Histochem Cytochem; 2010 Nov; 58(11):1015-23. PubMed ID: 20713982
[TBL] [Abstract][Full Text] [Related]
2. Expression of serum amyloid A, in normal, dysplastic, and neoplastic human colonic mucosa: implication for a role in colonic tumorigenesis.
Gutfeld O; Prus D; Ackerman Z; Dishon S; Linke RP; Levin M; Urieli-Shoval S
J Histochem Cytochem; 2006 Jan; 54(1):63-73. PubMed ID: 16116035
[TBL] [Abstract][Full Text] [Related]
3. The expression of Müllerian inhibiting substance/anti-Müllerian hormone type II receptor protein and mRNA in benign, borderline and malignant ovarian neoplasia.
Song JY; Chen KY; Kim SY; Kim MR; Ryu KS; Cha JH; Kang CS; MacLaughlin DT; Kim JH
Int J Oncol; 2009 Jun; 34(6):1583-91. PubMed ID: 19424576
[TBL] [Abstract][Full Text] [Related]
4. Serum amyloid a, a potential biomarker both in serum and tissue, correlates with ovarian cancer progression.
Li Z; Hou Y; Zhao M; Li T; Liu Y; Chang J; Ren L
J Ovarian Res; 2020 Jun; 13(1):67. PubMed ID: 32517794
[TBL] [Abstract][Full Text] [Related]
5. Serum amyloid A: expression throughout human ovarian folliculogenesis and levels in follicular fluid of women undergoing controlled ovarian stimulation.
Urieli-Shoval S; Finci-Yeheskel Z; Eldar I; Linke RP; Levin M; Prus D; Haimov-Kochman R
J Clin Endocrinol Metab; 2013 Dec; 98(12):4970-8. PubMed ID: 24030940
[TBL] [Abstract][Full Text] [Related]
6. GnRH-II mRNA expression in tumor tissue and peripheral blood mononuclear cells (PBMCs) in patients with malignant and benign ovarian tumors.
Serin IS; Tanriverdi F; Ata CD; Akalin H; Ozcelik B; Ozkul Y; Kelestimur F
Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):92-6. PubMed ID: 20018426
[TBL] [Abstract][Full Text] [Related]
7. Widespread expression of serum amyloid A in histologically normal human tissues. Predominant localization to the epithelium.
Urieli-Shoval S; Cohen P; Eisenberg S; Matzner Y
J Histochem Cytochem; 1998 Dec; 46(12):1377-84. PubMed ID: 9815279
[TBL] [Abstract][Full Text] [Related]
8. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.
Dong Y; Kaushal A; Bui L; Chu S; Fuller PJ; Nicklin J; Samaratunga H; Clements JA
Clin Cancer Res; 2001 Aug; 7(8):2363-71. PubMed ID: 11489814
[TBL] [Abstract][Full Text] [Related]
9. [Expression of mesothelin mRNA and protein in ovarian carcinomas].
Bi SN; Dai SZ; Yao Q; Che YC; Wang N
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):288-91. PubMed ID: 18788634
[TBL] [Abstract][Full Text] [Related]
10. Expression of FHIT in primary cultures of human epithelial ovarian tumors and malignant ovarian ascites.
Manning AP; Mes-Masson AM; Seymour RJ; Tetrault M; Provencher DM; Tonin PN
Mol Carcinog; 1999 Mar; 24(3):218-25. PubMed ID: 10204806
[TBL] [Abstract][Full Text] [Related]
11. Decreased luteinizing hormone receptor mRNA expression in human ovarian epithelial cancer.
Lu JJ; Zheng Y; Kang X; Yuan JM; Lauchlan SC; Pike MC; Zheng W
Gynecol Oncol; 2000 Nov; 79(2):158-68. PubMed ID: 11063638
[TBL] [Abstract][Full Text] [Related]
12. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma.
Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ
Gynecol Oncol; 2000 Jul; 78(1):10-5. PubMed ID: 10873402
[TBL] [Abstract][Full Text] [Related]
13. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
14. p14 expression differences in ovarian benign, borderline and malignant epithelial tumors.
Cabral VD; Cerski MR; Sa Brito IT; Kliemann LM
J Ovarian Res; 2016 Oct; 9(1):69. PubMed ID: 27770808
[TBL] [Abstract][Full Text] [Related]
15. Serum amyloid A expression in the breast cancer tissue is associated with poor prognosis.
Yang M; Liu F; Higuchi K; Sawashita J; Fu X; Zhang L; Zhang L; Fu L; Tong Z; Higuchi K
Oncotarget; 2016 Jun; 7(24):35843-35852. PubMed ID: 27058895
[TBL] [Abstract][Full Text] [Related]
16. p16 overexpression: a potential early indicator of transformation in ovarian carcinoma.
Shigemasa K; Hu C; West CM; Clarke J; Parham GP; Parmley TH; Korourian S; Baker VV; O'Brien TJ
J Soc Gynecol Investig; 1997; 4(2):95-102. PubMed ID: 9101469
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of serum amyloid A in head and neck squamous cell carcinoma.
Shinriki S; Ueda M; Ota K; Nakamura M; Kudo M; Ibusuki M; Kim J; Yoshitake Y; Fukuma D; Jono H; Kuratsu J; Shinohara M; Ando Y
J Oral Pathol Med; 2010 Jan; 39(1):41-7. PubMed ID: 19453393
[TBL] [Abstract][Full Text] [Related]
18. Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology.
Mok SC; Chao J; Skates S; Wong K; Yiu GK; Muto MG; Berkowitz RS; Cramer DW
J Natl Cancer Inst; 2001 Oct; 93(19):1458-64. PubMed ID: 11584061
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples.
Grisaru-Granovsky S; Salah Z; Maoz M; Pruss D; Beller U; Bar-Shavit R
Int J Cancer; 2005 Jan; 113(3):372-8. PubMed ID: 15455382
[TBL] [Abstract][Full Text] [Related]
20. Intestinal epithelial serum amyloid A modulates bacterial growth in vitro and pro-inflammatory responses in mouse experimental colitis.
Eckhardt ER; Witta J; Zhong J; Arsenescu R; Arsenescu V; Wang Y; Ghoshal S; de Beer MC; de Beer FC; de Villiers WJ
BMC Gastroenterol; 2010 Nov; 10():133. PubMed ID: 21067563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
